Literature DB >> 7784817

Prevalence of Cryptosporidium sp. in patients with neoplasia and diarrhea.

M Tanyüksel1, H Gün, L Doğanci.   

Abstract

The prevalence of Cryptosporidium sp. was investigated in fecal specimens from 106 patients with neoplasia and diarrhea (74 females, 32 males) by using Ziehl-Neelsen and Giemsa stains. Oocystic forms of Cryptosporidium sp. were found in 18 (17%) of these patients. No oocystic form of Cryptosporidium sp. was detected in the control group of 60 patients with neoplasia (37 females, 23 males) but without diarrhea. The frequent findings of Cryptosporidium sp. in patients with neoplasia and diarrhea who are undergoing chemotherapy indicates that a search for this organism is justified.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784817     DOI: 10.3109/00365549509018975

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens.

Authors:  L S Garcia; R Y Shimizu
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 2.  Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients.

Authors:  Paul R Hunter; Gordon Nichols
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Prevalence of cryptosporidium infection in immunocompromised patients, in South-west of iran, 2009-10.

Authors:  A Balouty Dehkordy; A Rafiei; Sm Alavi; Sm Latifi
Journal:  Iran J Parasitol       Date:  2010-12       Impact factor: 1.012

4.  Molecular Characterization of Cryptosporidium spp. Isolated From Immunocompromised Patients and Children.

Authors:  Abdollah Rafiei; Zahra Rashno; Alireza Samarbafzadeh; Shahram Khademvatan
Journal:  Jundishapur J Microbiol       Date:  2014-04-01       Impact factor: 0.747

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.